ABOUT ABBV-744

Here we exhibit that DNL343 minimizes ISR activation and neurodegeneration brought on acutely by an optic nerve crush (ONC) personal injury or chronically by a germline eIF2B LOF mutation in mice. We also present that DNL343 cure, initiated at a late stage of disorder which a lot more correctly replicates a scientific dosing paradigm, reversed thes